Phase II trial of prolonged infusion of low-dose gemcitabine in advanced non-small cell lung cancer treatment

Ai zheng = Aizheng = Chinese journal of cancer

Volumn 25, Issue 8, 2006, Pages 995-998

  Xiong, Jian Ping ^a   Zhang, Ling ^a   Zhong, Lu Xing ^a   Qiu, Feng ^a   Guo, Yu Ling ^a   Lian, Hong Yun ^a   Luo, Hui ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; CISPLATIN; DEOXYCYTIDINE; DRUG DERIVATIVE; GEMCITABINE;

ADULT; AGED; ARTICLE; CANCER STAGING; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MIDDLE AGED; NAUSEA; PATHOLOGY; PHASE 2 CLINICAL TRIAL; REMISSION; SURVIVAL RATE;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DEOXYCYTIDINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; LEUKOPENIA; LUNG NEOPLASMS; MALE; MIDDLE AGED; NAUSEA; NEOPLASM STAGING; REMISSION INDUCTION; SURVIVAL RATE;

EID: 42949132176     PISSN: 1000467X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)